Clinical Thought Leadership
Latest
-
![]()
Educational Articles
-
![Official announcements from Cizzle Bio regarding new products, strategic partnerships, financial reports, and other corporate communications.]()
Press Releases
-
![Updates on company milestones, industry news, collaborations, partnerships, and significant events related to Cizzle Bio and its impact on the biotechnology field.]()
News
-
![Detailed scientific studies and findings related to lung cancer detection, biomarker research, and other relevant medical research conducted or published by Cizzle Bio or related entities.]()
Research Papers
Clinical Thought Leadership Articles
Explore expert perspectives from leading physicians, researchers, and oncology specialists on the evolving role of biomarker-based technologies in cancer diagnostics. This series highlights clinical insights on early detection, diagnostic innovation, and real-world applications that are shaping the future of patient care.
Advancing Early Detection of Lung Cancer – Moffitt Cancer Center’s Clinical Trial of the CIZ1B Biomarker-Based Blood Test
A new clinical trial at Moffitt Cancer Center is evaluating the CIZ1B biomarker blood test—an early-detection tool with potential to improve lung cancer diagnosis and long-term monitoring.
A new clinical trial at Moffitt Cancer Center is evaluating the CIZ1B biomarker blood test—an early-detection tool with potential to improve lung cancer diagnosis and long-term monitoring.